| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |